Condition: Knee Osteoarthritis · Gonarthrosis; Primary · Total Knee Arthroplasty · Sponsor: Haseki Training and Research Hospital
This prospective observational cohort study aims to evaluate the association between perioperative dexamethasone administration and early postoperative recovery following primary total knee arthroplasty. In routine clinical practice, dexamethasone may be administered orally, intravenously, or not administered, depending on the surgeon's established perioperative protocol. The primary objective is to assess early postoperative recovery in terms of pain intensity, functional mobility, and knee joint range of motion. Secondary objectives include evaluation of inflammatory response, postoperative metabolic changes, opioid requirement, and the severity of postoperative nausea and vomiting (PONV). Group allocation is non-randomized and determined solely by the standard perioperative management approach routinely applied by the surgeon selected by the patient. No additional interventions are introduced for research purposes. All outcomes are assessed prospectively during the early postoperative period.
This description comes directly from the study's public registry record.
Atahan Eryilmaz, Resident Physician · +90 552 609 9055 · dratahaneryilmaz@gmail.com
Mehmet Ersin, Associate Professor · +90 507 788 60 54 · drmehmetersin@gmail.com
Always discuss trial participation with your own doctor first.
| Sultangazi Haseki Training and Research Hospital | Istanbul, Istanbul, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07442812